Stage IVA Colorectal Cancer Recruiting Phase 1 Trials for Ipilimumab (DB06186)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03373188VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerTreatment